Abstract
Gene therapy has enormous potential to treat a variety of infectious and genetic diseases. To date hundreds of patients worldwide have received hematopoietic cell products that have been gene-modified with retrovirus vectors carrying therapeutic transgenes, and many patients have been cured or demonstrated disease stabilization as a result (Adair et al., Sci Transl Med 4:133ra57, 2012; Biffi et al., Science 341:1233158, 2013; Aiuti et al., Science 341:1233151, 2013; Fischer et al., Gene 525:170–173, 2013). Unfortunately, for some patients the provirus integration dysregulated the expression of nearby genes leading to clonal outgrowth and, in some cases, cancer. Thus, the unwanted side effect of insertional mutagenesis has become a major concern for retrovirus gene therapy. The careful study of retrovirus integration sites (RIS) and the contribution of individual gene-modified clones to hematopoietic repopulating cells is of crucial importance for all gene therapy studies. Supporting this, the US Food and Drug Administration (FDA) has mandated the careful monitoring of RIS in all clinical trials of gene therapy. An invaluable method was developed: linear amplification mediated-polymerase chain reaction (LAM-PCR) capable of analyzing in vitro and complex in vivo samples, capturing valuable genomic information directly flanking the site of provirus integration. Linking this method and similar methods to high-throughput sequencing has now made possible an unprecedented understanding of the integration profile of various retrovirus vectors, and allows for sensitive monitoring of their safety. It also allows for a detailed comparison of improved safety-enhanced gene therapy vectors. An important readout of safety is the relative contribution of individual gene-modified repopulating clones. One limitation of LAM-PCR is that the ability to capture the relative contribution of individual clones is compromised because of the initial linear PCR common to all current methods. Here, we describe an improved protocol developed for efficient capture, sequencing, and analysis of RIS that preserves gene-modified clonal contribution information. We also discuss methods to assess dominant/overrepresented gene-modified clones in preclinical and clinical models.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Adair JE, Beard BC, Trobridge GD et al (2012) Extended survival of glioblastoma patients after chemoprotective HSC gene therapy. Sci Transl Med 4:133ra57
Hacein-Bey-Abina S, von Kalle C, Schmidt M et al (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415–419, erratum appears in Science. 2003 Oct 24;302(5645):568
Kustikova O, Fehse B, Modlich U et al (2005) Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 308:1171–1174
Ott MG, Schmidt M, Schwarzwaelder K et al (2006) Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 12:401–409
Bender MA, Gelinas RE, Miller AD (1989) A majority of mice show long-term expression of a human b-globin gene after retrovirus transfer into hematopoietic stem cells. Mol Cell Biol 9:1426–1434
Cavazza A, Moiani A, Mavilio F (2013) Mechanisms of retroviral integration and mutagenesis. Hum Gene Ther 24:119–131
Nolta JA, Dao MA, Wells S et al (1996) Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc Natl Acad Sci U S A 93:2414–2419
Devon RS, Porteous DJ, Brookes AJ (1995) Splinkerettes–improved vectorettes for greater efficiency in PCR walking. Nucleic Acids Res 23:1644–1645
Tisdale JF, Hanazono Y, Sellers SE et al (1998) Ex vivo expansion of genetically marked Rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 92:1131–1141
Wu T, Kim HJ, Sellers SE et al (2000) Prolonged high-level detection of retrovirally marked hematopoietic cells in nonhuman primates after transduction of CD34+ progenitors using clinically feasible methods. Mol Ther 1:285–293
Kim HJ, Tisdale JF, Wu T et al (2000) Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates. Blood 96:1–8
Schmidt M, Hoffmann G, Wissler M et al (2001) Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum Gene Ther 12:743–749
Schmidt M, Glimm H, Lemke N et al (2001) A model for the detection of clonality in marked hematopoietic stem cells. Ann NY Acad Sci 938:146–155
Wu X, Li Y, Crise B, Burgess SM (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749–1751
Paruzynski A, Arens A, Gabriel R et al (2010) Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing. Nat Protoc 5:1379–1395
Ronen K, Negre O, Roth S et al (2011) Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat -thalassemia. Mol Ther 19:1273–1286
Wang GP, Garrigue A, Ciuffi A et al (2008) DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer. Nucleic Acids Res 36:e49
Beard BC, Trobridge GD, Ironside C et al (2010) Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates. J Clin Invest 120:2345–2354
Uren AG, Kool J, Berns A et al (2005) Retroviral insertional mutagenesis: past, present and future. Oncogene 24:7656–7672
Quail MA, Kozarewa I, Smith F et al (2008) A large genome center’s improvements to the Illumina sequencing system. Nat Methods 5:1005–1010
Trobridge GD, Miller DG, Jacobs MA et al (2006) Foamy virus vector integration sites in normal human cells. Proc Natl Acad Sci U S A 103:1498–1503
Beard BC, Dickerson D, Beebe K et al (2007) Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells. Mol Ther 15:1356–1365
Beard BC, Keyser KA, Trobridge GD et al (2007) Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, and foamy virus. Hum Gene Ther 18:423–434
Kent WJ (2002) BLAT–the BLAST-like alignment tool. Genome Res 12:656–664
Smith TF, Waterman MS (1981) Identification of common molecular subsequences. J Mol Biol 147:195–197
Cartier N, Hacein-Bey-Abina S, Bartholomae CC et al (2009) Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326:818–823
Biffi A, Montini E, Lorioli L et al (2013) Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341:1233158
Schmidt M, Schwarzwaelder K, Bartholomae CC et al (2009) Detection of retroviral integration sites by linear amplification-mediated PCR and tracking of individual integration clones in different samples. Methods Mol Biol 506:363–372
Acknowledgements
The authors would like to thank Allie Evans and Sum-Ying Chiu for their technical assistance in conduct of this work. We also acknowledge the assistance of Grace Choi in preparing the manuscript. This work is supported in part by grants DK076973 (B.C.B.), HL115128, HL116217, HL098489, CA114218, HL085693, and AI097100 (H.P.K.) from the National Institutes of Health, Bethesda, MD. H.P.K. is a Markey Molecular Medicine Investigator and the recipient of the José Carreras/E.D. Thomas Endowed Chair for Cancer Research.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Beard, B.C., Adair, J.E., Trobridge, G.D., Kiem, HP. (2014). High-Throughput Genomic Mapping of Vector Integration Sites in Gene Therapy Studies. In: Bunting, K., Qu, CK. (eds) Hematopoietic Stem Cell Protocols. Methods in Molecular Biology, vol 1185. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1133-2_22
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1133-2_22
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1132-5
Online ISBN: 978-1-4939-1133-2
eBook Packages: Springer Protocols